Original Research

Published on 25 Mar 2022

Long-Term Real-World Outcomes of First-Line Pembrolizumab Monotherapy for Metastatic Non-Small Cell Lung Cancer With ≥50% Expression of Programmed Cell Death-Ligand 1

in Thoracic Oncology

Vamsidhar Velcheti
Xiaohan Hu
Lingfeng Yang
M. Catherine Pietanza
Thomas Burke

Frontiers in Oncology

doi 10.3389/fonc.2022.834761

9,015 views
22 citations

Original Research

Published on 21 Mar 2022

EGFR Q787Q Polymorphism Is a Germline Variant and a Prognostic Factor for Lung Cancer Treated With TKIs

in Thoracic Oncology

Wen-Jui Wu
Sheng-Hsiung Yang
Hsin-Pei Chung
Chia-Te Yen
Yen-Ting Chen
Wei-Chin Chang
Jian Su
Hsuan-Yu Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.816801

2,346 views
2 citations

Original Research

Published on 18 Mar 2022

Based on SEER Database: Population Distribution, Survival Analysis, and Prognostic Factors of Organ Metastasis of Lung Large Cell Neuroendocrine Carcinoma

in Thoracic Oncology

Chang-fu Liu
Yu-jian Tao

Frontiers in Oncology

doi 10.3389/fonc.2022.810170

4,122 views
4 citations

Review

Published on 17 Mar 2022

NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor Resistance

in Thoracic Oncology

Fangfang Liu
Yuxuan Wei
Huan Zhang
Jizong Jiang
Peng Zhang
Qian Chu

Frontiers in Oncology

doi 10.3389/fonc.2022.864666

21,223 views
53 citations

Original Research

Published on 17 Mar 2022

Analgesic Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Advanced Non-Small-Cell Lung Cancer: A Randomized, Sham-Controlled, Pilot Study

in Thoracic Oncology

Ying Tang
Han Chen
Yi Zhou
Ming-liang Tan
Shuang-long Xiong
Yan Li
Xiao-hui Ji
Yong-sheng Li

Frontiers in Oncology

doi 10.3389/fonc.2022.840855

2,510 views
7 citations

Original Research

Published on 17 Mar 2022

Comparison of the Detection Rates of Different Diagnostic Methods for Primary Peripheral Lung Cancer

in Thoracic Oncology

Lijuan Sun
Chao Qin
Qun Fu
Shuangmin Hu
Wenfei Zhao
Hongyun Li

Frontiers in Oncology

doi 10.3389/fonc.2021.696239

2,236 views
5 citations

Correction

Published on 15 Mar 2022

Corrigendum: Long Non-Coding RNA AL513318.2 as ceRNA Binding to hsa-miR-26a-5p Upregulates SLC6A8 Expression and Predicts Poor Prognosis in Non-Small Lung Cancer

in Thoracic Oncology

Yongfei Fan
Yong Zhou
Xinwei Li
Ming Lou
Zhaojia Gao
Kai Yuan
Jichun Tong

Frontiers in Oncology

doi 10.3389/fonc.2022.878864

1,195 views
2 citations

Original Research

Published on 15 Mar 2022

Drug-Eluting Bead Bronchial Arterial Chemoembolization With and Without Microwave Ablation for the Treatment of Advanced and Standard Treatment-Refractory/Ineligible Non-Small Cell Lung Cancer: A Comparative Study

in Thoracic Oncology

Sheng Xu
Zhi-Xin Bie
Yuan-Ming Li
Bin Li
Fan-Lei Kong
Jin-Zhao Peng
Xiao-Guang Li

Frontiers in Oncology

doi 10.3389/fonc.2022.851830

2,466 views
13 citations

Review

Published on 15 Mar 2022

Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update

in Thoracic Oncology

Joanna Kapeleris
Majid Ebrahimi Warkiani
Arutha Kulasinghe
Ian Vela
Liz Kenny
Rahul Ladwa
Kenneth O’Byrne
Chamindie Punyadeera

Frontiers in Oncology

doi 10.3389/fonc.2022.859152

6,387 views
20 citations

Original Research

Published on 15 Mar 2022

Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma

in Thoracic Oncology

Longjun Yang
Guangran Guo
Xiangyang Yu
Yingsheng Wen
Yongbin Lin
Rusi Zhang
Dechang Zhao
Zirui Huang
Gongming Wang
Yan Yan

Frontiers in Oncology

doi 10.3389/fonc.2022.780631

2,221 views
6 citations

Original Research

Published on 10 Mar 2022

Deleterious AHNAK2 Mutation as a Novel Biomarker for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

in Thoracic Oncology

Yanan Cui
Xinyin Liu
Yuemin Wu
Xiao Liang
Jiali Dai
Zhihong Zhang
Renhua Guo

Frontiers in Oncology

doi 10.3389/fonc.2022.798401

3,952 views
8 citations

Original Research

Published on 10 Mar 2022

Fibroblast Activation Protein Specific Optical Imaging in Non-Small Cell Lung Cancer

in Thoracic Oncology

Layla Mathieson
Richard A. O’Connor
Hazel Stewart
Paige Shaw
Kevin Dhaliwal
Gareth O. S. Williams
Alicia Megia-Fernandez
Ahsan R. Akram

Frontiers in Oncology

doi 10.3389/fonc.2022.834350

5,046 views
2 citations

Original Research

Published on 08 Mar 2022

The Effect of Extracellular Superoxide Dismutase (SOD3) Gene in Lung Cancer

in Thoracic Oncology

Yundi Zhang
Xuan Lu
Yueyang Zhang
Dongbo Zhao
Haoming Gong
Yuxin Du
Hua Sun

Frontiers in Oncology

doi 10.3389/fonc.2022.722646

3,242 views
7 citations

Brief Research Report

Published on 07 Mar 2022

Is There a Role for Large Exome Sequencing in the Management of Metastatic Non-Small Cell Lung Cancer: A Brief Report of Real Life

in Thoracic Oncology

Lorraine Dalens
Julie Niogret
Courèche Guillaume Kaderbhai
Romain Boidot

Frontiers in Oncology

doi 10.3389/fonc.2022.863057

1,994 views
4 citations

Correction

Published on 03 Mar 2022

Corrigendum: Construction and Validation of a Lung Cancer Risk Prediction Model for Non-Smokers in China

in Thoracic Oncology

Lan-Wei Guo
Zhang-Yan Lyu
Qing-Cheng Meng
Li-Yang Zheng
Qiong Chen
Yin Liu
Hui-Fang Xu
Rui-Hua Kang
Lu-Yao Zhang
Xiao-Qin Cao

Frontiers in Oncology

doi 10.3389/fonc.2022.871848

1,259 views
2 citations

Original Research

Published on 03 Mar 2022

NcRNA-Mediated High Expression of HMMR as a Prognostic Biomarker Correlated With Cell Proliferation and Cell Migration in Lung Adenocarcinoma

in Thoracic Oncology

Xiulin Jiang
Lin Tang
Yixiao Yuan
Juan Wang
Dahang Zhang
Kebao Qian
William C. Cho
Lincan Duan

Frontiers in Oncology

doi 10.3389/fonc.2022.846536

3,328 views
9 citations

Navigation group

Articles

Long-Term Real-World Outcomes of First-Line Pembrolizumab Monotherapy for Metastatic Non-Small Cell Lung Cancer With ≥50% Expression of Programmed Cell Death-Ligand 1

EGFR Q787Q Polymorphism Is a Germline Variant and a Prognostic Factor for Lung Cancer Treated With TKIs

Based on SEER Database: Population Distribution, Survival Analysis, and Prognostic Factors of Organ Metastasis of Lung Large Cell Neuroendocrine Carcinoma

NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor Resistance

Analgesic Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Advanced Non-Small-Cell Lung Cancer: A Randomized, Sham-Controlled, Pilot Study

Comparison of the Detection Rates of Different Diagnostic Methods for Primary Peripheral Lung Cancer

Corrigendum: Long Non-Coding RNA AL513318.2 as ceRNA Binding to hsa-miR-26a-5p Upregulates SLC6A8 Expression and Predicts Poor Prognosis in Non-Small Lung Cancer

Drug-Eluting Bead Bronchial Arterial Chemoembolization With and Without Microwave Ablation for the Treatment of Advanced and Standard Treatment-Refractory/Ineligible Non-Small Cell Lung Cancer: A Comparative Study

Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update

Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma

Deleterious AHNAK2 Mutation as a Novel Biomarker for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Fibroblast Activation Protein Specific Optical Imaging in Non-Small Cell Lung Cancer

The Effect of Extracellular Superoxide Dismutase (SOD3) Gene in Lung Cancer

Is There a Role for Large Exome Sequencing in the Management of Metastatic Non-Small Cell Lung Cancer: A Brief Report of Real Life

Corrigendum: Construction and Validation of a Lung Cancer Risk Prediction Model for Non-Smokers in China

NcRNA-Mediated High Expression of HMMR as a Prognostic Biomarker Correlated With Cell Proliferation and Cell Migration in Lung Adenocarcinoma